Kalytera Announces Binding Agreement to Acquire Salzman Group
Hit enter to search or ESC to close
Kalytera Therapeutics, Inc.Kalytera Therapeutics, Inc.Kalytera Therapeutics, Inc.
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

Press Release Archive

Menu
  • Overview
  • Press Releases
  • Company Information
  • Stock Information
  • Sedar Filings
  • Corporate Governance

Recent Press Releases

December 30, 2016
Kalytera (formerly Santa Maria Petroleum Inc.) Closes Reverse Takeover Transaction
December 14, 2016
Kalytera Appoints Dr. Andrew Salzman as Chief Executive Officer
August 23, 2016
Kalytera Appoints Dr. Andrew Salzman as Chief Medical Officer
August 8, 2016
Kalytera to Study Genetic Markers of Osteoporosis in Patients with Prader-Willi Syndrome
July 20, 2016
Kalytera Presents New Data Demonstrating KAL671’s Ability to Prevent Bone Loss in a Prader-Willi Syndrome Animal Model
July 5, 2016
Kalytera to Present New Data that Supports the Continued Investigation of KAL671 for the Treatment of Osteoporosis in Prader-Willi Syndrome at the IPWSO Conference
June 29, 2016
Kalytera Appoints Robert Farrell as President and Chief Financial Officer
June 27, 2016
Kalytera Appoints Dr. Stuart Silverman as Senior Vice President of Medical Affairs
June 23, 2016
Kalytera Appoints Robert S. Langer to the Scientific Advisory Board
June 2, 2016
Kalytera Licenses Transdermal Drug Delivery Technology from Delivra Corp.
March 17, 2016
Kalytera and Ramot at Tel Aviv University to Study Novel Approach to Treating Osteogenesis Imperfecta
February 15, 2016
Dr. Raphael Mechoulam to Deliver Keynote Presentation at the 2016 CannaTech Conference

Browse by Year

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Get Email Alerts Subscribe

New Website Coming Soon


© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

© 2016 Kalytera Therapeutics, Inc.